Perioperative Virtual Reality Intervention for Pain and Anxiety During Vasectomies
Launched by UNIVERSITY OF MANITOBA · Jul 3, 2025
Trial Information
Current as of July 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether using virtual reality (VR) can help reduce pain, anxiety, and stress for men having a vasectomy—a common procedure for male birth control—done with local anesthesia (numbing medicine). During the vasectomy, some men still feel uncomfortable or anxious, so researchers want to see if wearing a VR headset with a calming, guided meditation program (called TRIPP) can make the experience better compared to the usual care without VR.
Men who are 18 or older, speak English, and have chosen to have a vasectomy at the Men’s Health Clinic may be eligible to join. Participants will be randomly placed into two groups: one will use the VR headset during the procedure, and the other will have the vasectomy as usual. Everyone will fill out short questionnaires before, during, and after the procedure to share how they feel. Those using VR will also have a chance to give feedback about their experience. This study aims to find out if VR can be a helpful tool to make vasectomies less stressful and more comfortable for future patients.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • 18 years of age or older.
- • Can speak and read English.
- • Have elected for a vasectomy.
- • Are scheduled to undergo their vasectomy under local anesthesia at the Men's Health Clinic
- Exclusion Criteria:
- • Those who are not competent to provide informed consent (e.g., due to cognitive impairment).
- • Those who are unable to participate in a VR intervention (e.g., due to visual or auditory impairment).
About University Of Manitoba
The University of Manitoba, a leading research institution in Canada, is dedicated to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its extensive expertise in medical research, public health, and community engagement to conduct rigorous and ethical clinical studies. The institution aims to translate scientific findings into practical applications that enhance patient care and improve health outcomes. Committed to fostering a culture of excellence and integrity, the University of Manitoba prioritizes participant safety and scientific validity in all its clinical research endeavors.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Winnipeg, Manitoba, Canada
Patients applied
Trial Officials
Renée El-Gabalawy, MA, PhD, C. Psych
Principal Investigator
University of Manitoba
Premal Patel, MD, FRCSC
Principal Investigator
Manitoba Men's Health Clinic
Ahmed M Zalam, B.Sc.
Principal Investigator
University of Manitoba
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported